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Abstract:  This study explored challenges to continuing an HIV post-exposure prophylaxis (PEP) program of care 
provided to sexual assault survivors in the province of Ontario, Canada. Data were collected as part of an implementation 
and evaluation of a universal offering of HIV PEP (known as the HIV PEP Program) at 24 of 34 provincial hospital-based 
sexual assault treatment centres. Experienced health care providers were surveyed (n = 132) and interviewed in four focus 
groups (n = 26) about their perceptions of what, if any, factors threatened their ability to maintain the HIV PEP Program. 
All focus groups were audio-recorded and the recordings transcribed. The transcriptions and open-ended survey responses 
were analyzed using content analysis. Administrator, nurse, physician, social worker, and pharmacist respondents 
perceived important barriers to sustainability of the HIV PEP Program. Eight constructs were identified within four broad 
themes: resources (inadequate funds, overworked and unacknowledged staff), expertise (insufficient external supports, 
insufficiently trained and knowledgeable staff), commitment (lack of institutional support, physician resistance to offering 
HIV PEP), and accommodation (lack of flexibility in addressing specific client and community needs, inaccessibility and 
lack of clarity of tools). We discuss the implications of these findings and the actions that were taken to address the 
challenges. 
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INTRODUCTION 
  Sexual assault is a wide-spread human rights problem 
with potentially devastating health consequences [1, 2]. 
Persons who have been assaulted may experience 
depression, post-traumatic stress disorder, suicidality, 
substance abuse problems, eating disorders, gynaecological 
problems, genital and extragenital injuries, as well as 
sexually transmitted infections (STIs) [3-14]. Particular 
characteristics of sexual assaults may increase the likelihood 
of transmission of HIV specifically: those involving multiple 
assailants; perpetration of multiple sex acts, including anal 
penetration; occurrence of injury to mucous membranes; and 
the presence of preexisting STIs [7, 8, 15]. Research has 
shown that sexual assault survivors are often afraid of 
contracting HIV infection and that they want access to 
appropriate antiretroviral therapies [16-23]. 
  The World Health Organization [24] maintains that “all 
countries should have a policy on the services provided for 
people who have been sexually assaulted and that these 
policies should include post-exposure prophylaxis for HIV 
whenever sufficient resources are available” (p. 54). In fact,  
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guidelines and protocols for HIV PEP following sexual 
assault have been increasingly developed over time [7, 11, 
24-37]. There is also a growing number of studies that have 
evaluated such guidelines and protocols, although most of 
these have been retrospective chart reviews [18, 32, 38-52], 
many focussed on children and/or adolescents only [40, 42, 
45, 47, 52-56], or conducted in mid-to-high HIV prevalent 
countries [38, 53, 54, 57-59]. Although most of these studies 
have concluded that there is a need to further “evaluate and 
improve appropriateness of HIV nPEP administration and 
follow-up” (41: p.640), none have interviewed and surveyed 
health care providers about their opinions and experiences of 
offering PEP to sexual assault survivors. 
THE HIV PEP STUDY 
  The HIV PEP Study, as it was known, was the first large, 
systematic, and prospective research to address a program of 
offering HIV PEP to women, men, and children after sexual 
assault in a country with a low prevalence of infection. In 
2003, concern about this issue of HIV for sexually assaulted 
persons prompted the Ontario Network of Sexual 
Assault/Domestic Violence Treatment Centre (SA/DVTC)s 
to partner sexual assault experts with infectious disease 
specialists to implement and evaluate a provincial program 
of universal offering of HIV PEP medications (known as the 
HIV PEP Program). Protocols were developed and 
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counselling and the option of antiretroviral medications 
(Combivir
® and Kaletra
®). Standardized medical guidelines, 
counselling tools, client handouts, and data collection forms 
assisted clinicians in providing consistent HIV PEP care. 
The primary purpose of the study was to generate scientific 
evidence for the practices needed to sustain a province-wide 
HIV PEP Program at SA/DVTCs (see 60 for more details). 
  The HIV PEP Program was characterized by the 
following specific characteristics: all clients were to receive 
counselling about potential HIV risks; all clients whose 
assault posed any risk of HIV infection (known or unknown) 
were to be offered prophylactic medication; prophylaxis was 
to be initiated within 72 hours of exposure and to be 
prescribed for a period of 28-days; an intensive schedule of 
five follow-up visits was to assist clients who chose the 
prophylactic drugs to cope with side effects and complete the 
medication course; and prophylaxis was to be provided at no 
cost to clients. The HIV
  PEP medications were dispensed 
through the hospital pharmacies and costs were reimbursed 
through the study. To ensure that the protocol was 
implemented consistently, an experienced sexual assault 
nurse examiner (SM) and/or infectious disease specialist 
(ML) held six regional train-the-trainer sessions involving 
three core staff from each participating center. These 
individuals in turn trained the front line staff at their sites 
[see 60 for more details]. 
  Of Ontario’s 34 SA/DVTCs, 24 (70%) were enrolled in 
the HIV PEP Study. These centres, administered by program 
coordinators, provided around the clock emergency medical 
care, counselling, and medical forensic examination to 
sexually assaulted women, men and children. The clients 
served were representative of the province’s rural, remote, 
and urban communities and ethnically diverse populations 
[61, 62]. Information was collected from 1,238 sexual 
assault survivors from September 10, 2003 to January 31, 
2005. Data from 135 of these clients were excluded from 
analyses because of inconsistent data collection practices at 6 
SA/DVTCs, leaving a final total sample size of 1,103. 
Findings showed that 347 (44%) of the 798 clients who met 
the HIV risk criteria and were offered HIV PEP, accepted; 
111 (32%) of this latter group completed the full 28-day 
regimen [see 60 and 63 for more details]. These findings 
compare to a 28% acceptance rate and an 11% completion 
rate reported in a smaller retrospective study conducted at 
the British Columbia Sexual Assault Service between 1996 
and 1998. The higher rate of adherence in the HIV PEP 
Study may be related to the fact that clients were tracked 
prospectively and provided a rigorous schedule of follow-up 
that included both emotional and physical support, as well as 
offered a newer drug regimen that may have been easier to 
tolerate [50]. 
  As part of the HIV PEP Study, different health care 
providers were surveyed and interviewed in focus groups 
about their experiences implementing the protocol, offering 
some insight into challenges that were encountered 
(administrators, nurses, physicians, social workers, and 
pharmacists). Their perceptions and experiences were 
solicited to help ensure that any recommendations regarding 
standards of care that emerged from the HIV PEP Study 
findings could be implemented at all SA/DVTCs across 
Ontario. Knowledge gained from understanding the barriers 
to rolling out such a program of care could inform those 
embarking on similar processes in other jurisdictions. 
METHOD 
  This study was approved by the Institutional Review 
Boards of all participating hospitals as well as by their 




  A survey was developed to capture the different health 
care providers’ views regarding the universal offering of 
HIV PEP. Topics covered by the survey included: 1) client 
ability to make informed decisions about HIV PEP; 2) health 
care provider ability to provide sufficient counselling about 
HIV PEP; 3) influence of health care provider strength of 
recommendation on client decision to take HIV PEP; 4) 
client satisfaction with HIV PEP care received; 5) impact of 
HIV PEP care on other aspects of care offered; 6) 
importance of offering HIV PEP to unknown risk group; 7) 
optimal strategy for offering HIV PEP; and 8) sustainability 
of an HIV PEP program. With regard to the latter, the 
following question, specifically, was asked: “Thinking about 
the impact that the HIV PEP and universal offering had on 
the nurses, physicians, administrators, pharmacists, and 
social workers at your hospital, do you think universally 
offering of HIV PEP to SA/DVTC clients is sustainable at 
your hospital on a long-term basis?” This question was 
followed by space for the respondent to comment further or 
explain their response. Prior to distribution, the Health Care 
Provider Survey was piloted in October 2004 with the 
assistance of SA/DVTC program coordinators and staff 
members across the province. Based on their feedback, small 
changes were made to the survey design and content. 
Focus Group Interview Guide 
  The intent of the focus groups was to allow for an in-
depth exploration of the experiences and perceptions of 
health care providers in delivering the universal HIV PEP 
Program. A semi-structured interview guide was developed 
to elicit information about the following: 1) the satisfaction 
of clients with the HIV PEP Program; 2) optimal strategy for 
offering HIV PEP to clients; 3) validity of HIV PEP 
universal offering strategy; and 4) sustainability of an HIV 
PEP Program. Regarding sustainability, specifically, health 
care providers were asked: “Now I’d like you to think for a 
minute about HIV PEP as an ongoing program. Do you think 
your centre can keep it going?” Probes included: Do you 
think that your host hospital and centre would be supportive? 
Would your centre be able to continue providing the kind of 
support and counselling that are needed to continue with 
“universal offering”? The guide was piloted in a November 
2004 focus group and based on feedback slight changes were 
made to ensure that any pertinent feedback from health care 
providers was captured. 
Procedure 
Survey 
  All health care providers (i.e., administrators, nurses, 
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participated in the HIV PEP Study were invited to complete 
the anonymous and voluntary survey. In November 2004, 
program coordinators at the 24 participating sites distributed 
surveys, which included an attached pre-addressed, postage 
paid return envelope, to program health care providers. 
Reminders to distribute surveys among staff were sent via e-
mail 2, 6, and 8 weeks post-distribution. As well, a section in 
the quarterly HIV PEP Study newsletter was devoted to 
reminding health care providers about the importance of 
their feedback via  the survey. Completed surveys were 
returned to the central study coordinator, entered into a MS 
Access database, and then filed in a secure cabinet. Only 
members of the research team had access to the surveys and 
the database, the latter of which was restricted by password. 
Focus Groups 
  All health care providers who had participated in the HIV 
PEP Study were invited to take part in one of several 
proposed focus groups. An effort was made to set up varying 
days and times to reach as many health care providers as 
possible. Once the schedule had been established, an email 
was sent to all program coordinators to enlist their help in 
publicizing the upcoming focus groups. A flyer was also sent 
as an attachment to be posted at all participating sites and a 
section in the HIV PEP Study newsletter was devoted to 
reminding health care providers about the importance of 
their feedback via focus group participation. Focus groups, 
which were held in November and December 2004, were 
teleconferenced to ensure that as many health care providers 
as possible could participate. All focus groups were recorded 
and later professionally transcribed verbatim. A research 
assistant experienced in qualitative research reviewed the 
recordings to check for transcription errors. Focus group 
recordings and transcripts were secured in a locked cabinet; 
only members of the research team and the transcriber had 
access to them. 
Data Analysis 
  The first author and a research assistant experienced in 
qualitative research read the comments made on the surveys and 
each interview transcript twice. All qualitative data from the 
survey and focus groups related to barriers to sustainability and 
further implementation of the HIV PEP Program were then 
manually extracted and organized into a grid based on an initial 
manifest content analysis [64]. Emergent patterns were 
identified from this data, beginning at the higher order of 
categorization with four broad conceptual themes: ‘Resources’, 
‘Expertise’, ‘Commitment’, and ‘Accommodation’. A theme 
sheet was produced in which all data relating to those concepts 
were placed. Drawing on meaningful commonalities found 
across responses within each cluster, a series of lower order 
constructs were independently derived. These constructs were 
compared and any differences that emerged were resolved 
through consensus. Finally, responses identified in each cons-
truct were referenced back to the transcripts for further context 
and extraction of relevant quotations for latent content analysis. 
RESULTS 
Description of Respondents 
  A total of 35.2% of the health care providers contacted 
agreed to participate and completed the survey, resulting in a 
sample size of 132. Respondents included 18 program 
coordinators (15 of who were Sexual Assault Nurse 
Examiner [SANE]s and 3 social workers), 94 nurses (64 of 
who were SANEs), 11 physicians (5 of who were program 
medical directors), 4 social workers, and 5 pharmacists. 
Most had had direct patient contact: 94 had provided initial 
and 40 follow-up care. 
  Focus groups were also held with 26 health care 
providers representing nine centres from across the province. 
Focus Group 1 (n=14) included one program coordinator 
(also a social worker), ten SANEs, two social workers, and 
one physician; Focus Group 2 (n=2) included one program 
coordinator (also a SANE) and a SANE; Focus Group 3 
(n=6) included three program coordinators (also all SANEs), 
a SANE, a nurse, and a pharmacy manager; and Focus 
Group 4 (n=4) included two program coordinators (also both 
SANEs) and two nurses. 
Thematic Overview 
  The majority of health care providers surveyed (65.2%) 
and interviewed who answered the question, “Is universal 
offering of HIV PEP sustainable at your hospital on a long-
term basis?” believed the HIV PEP Program could continue 
and be further implemented across the province. However, 
many qualified their affirmative responses stating that 
viability of the program in the longer-term would be 
contingent upon several conditions being met. Along with 
those who did not believe the program was sustainable or 
who were unsure of its sustainability, their concerns, as 
captured in both the survey and focus groups comments, 
centered primarily on the need for the program for increased 
resources, expertise, commitment, and accommodation. 
Resources 
Inadequate Funds 
  Several health care providers were concerned about the 
monies to support the program, as indicated by one SANE’s 
comment, “what I see as the big hurdle is funding” (Focus 
Group (FG) 3 Respondent (R) 5; also FG 2 R 2 and Survey 
[Surv] Rs 12, 118, 120, 121, 127, 132). Much of the concern 
centred on adequate monies to cover the costs of the drug 
regimen as captured by this query from a pharmacist, “Who 
will fund the treatment?” (Surv R 59). A physician 
colleague, who declared himself to the “the last person that 
ever thinks about this kind of thing”, worried that limited 
funding for “a very expensive treatment” (FG 1 R14) would 
make decisions to offer HIV PEP universally difficult as the 
program expanded: 
There’s not an endless amount of money 
available to give to the program, to give drugs to 
people and … if you have a finite number of 
dollars … with which to spend on a program like 
this and you had to start designating and being 
the one to make a decision, like who warrants the 
sum of money that’s required for the treatment 
and who doesn’t, it’s very difficult for us as 
individuals to take that into consideration when 
the woman is sitting in front of you and you’ve 
got to decide whether she’s worth $1,500 or not 
for the treatment and yet if you are dealing with 
an infinitesimally small risk with someone who 
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only got so much money … is that something 
that you have to take into consideration? Maybe 
in the infancy of a program like this you’re not 
really thinking that way, but as you get more 
involved in it, and the numbers will add up over 
the years and the available number of dollars is 
not going to get greater in all probability, you 
have to start thinking that way. (FG 1 R 14) 
  Without external funding for the drugs, many health care 
respondents believed that the hospitals would not be able to 
continue the program (FG 3 Rs 1, 6, FG 4 Rs 2, 3; Surv Rs 
45, 58, 72, 97). A SANE stated that she “couldn’t see clients 
using their own health plans to cover the cost of antivirals 
because of the lack of confidentiality” (Surv R 3). In any 
event, a program coordinator noted, “most of the clients 
don’t have drug plans and if they do, they are very limited” 
(Surv R 79). This was seen as a particular problem by one 
program coordinator (SANE), whose program provided 
services to First Nation’s communities: 
One of the medications is covered for 
Aboriginal clients but the other one isn’t so 
we’d have to look at funding for, I can’t 
remember which one it is, but the second 
medication, so we’re okay with about half of 
the treatments. (FG 3 R 3) 
  Still others were worried about the sustainability of the 
program in terms of compensation for existing staff and 
funds for new staff. A program coordinator (social worker) 
asked, “What kind of support is there going to be … in terms 
of … remuneration for those involved with it, because it is 
asking yet another thing for us to do?” (FG 1 R 1). This was 
seen as a particular problem for health care providers 
delivering the follow-up care as captured in the statement of 
another program coordinator (SANE): 
With the nurses taking the lead as we have 
been the program can continue. However, staff 
funding resources for the follow-up nursing 
role will be a potential barrier that on a long-
term basis would need to be addressed. (Surv 
R 79; also Surv Rs 38, 45, 100) 
  She felt that there “would be a need for more funds to 
increase the follow-up nursing positions to full time” (Surv 
R 79; also Surv R 3). 
Overworked and Unacknowledged Staff 
  Several health care provider respondents with concerns 
about the sustainability of the HIV PEP Program cited 
overtaxed staff as an issue (Surv Rs 45, 86, 132). A 
pharmacist noted: 
I would like to be more involved with 
counselling the patient, especially those on 
many drugs, but our hospital is down to less 
than a half-staff of pharmacists. It is therefore 
hard to cover all the programs we would wish. 
(Surv R 15) 
  A program coordinator (SANE) who had been involved 
also in providing direct HIV PEP care added that in her 
centre she had “heard from pharmacy it was added 
workload” (Surv R 43). She continued by describing the 
additional burden the program created for her: 
I did all the follow-ups – I do not have clerical 
support – calling, rebooking, etc. It is difficult 
when programs see 25 or less clients per year. 
Requires a lot of arranging each time through 
the emergency room where I am also manager. 
(Surv R 43) 
  According to another program coordinator (SANE), “it is 
a huge workload issue for tracking clients, organizing 
follow-up, and completing the paperwork” (Surv R 73). “It 
takes an extremely long time to go through all advantages 
and disadvantages of HIV PEP” (Surv R 26, SANE; also FG 
1 R 5; Surv R 111). A program coordinator (social worker) 
explained: 
To sustain a programme you need to … 
acknowledge the time it takes to do this work, 
and often times a follow up is when patients 
will … want to spend more time, exploring, 
getting more information … so … 
appointments aren’t just … here’s your meds, 
go. It’s about sitting down with someone, 
doing the blood work … to make sure they’re 
okay …. There could be some lessons learned. 
… There’s a lot of unseen work and 
unrecognized work. …Without some kind of 
acknowledgment of this, the infrastructure 
that’s required to offer a program, at the 
calibre I think we do, can’t be sustained on an 
ongoing basis. (FG 1 R 1) 
Expertise 
Insufficient External Supports 
  Several health care provider respondents indicated that to 
maintain the program, external supports were necessary to 
ensure that the protocol (and accompanying forms and hand 
outs) was updated as required with current information about 
the optimal HIV PEP regimen that should be offered. A 
program coordinator (SANE) explained: 
If we do continue the program without the 
study in place – the study has given us 
invaluable support and information and 
education – to keep us updated in all this stuff 
…, we would be somewhat at a loss of where 
we would access that information. (FG 3, R 2) 
  Her colleague, a nurse, echoed this concern: 
Yes, even keeping … the latest information in 
the client booklets …, I’m sort of saying we 
need someone to support us with the latest 
information so that we’re able to … provide a 
consistent program. (FG 3, R 4) 
  Several others also indicated that availability of HIV 
experts would be needed to continue to offer the program: 
I would be interested in knowing … if the HIV 
experts that are participating in this study will 
continue to give us consultation information if 
we require it (FG 3, R 1, program coordinator 
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“That …for sure”, her colleague added, is “one 
of our concerns” (FG 3 R 3, program 
coordinator [SANE]). 
Insufficiently Trained and Knowledgeable Staff 
  A number of health care providers stated that 
inadequately trained and knowledgeable staff would be a 
barrier to an ongoing HIV PEP program, particularly with 
regard to participating physicians. A program coordinator 
(social worker) stated matter of factly, “emergency room 
physicians need to continue to be educated about HIV” (Surv 
R 42). 
  Several others health care providers agreed: 
We have to talk to our Medical Director and if 
he’s not around … which sometimes he’s not, 
we go to the emergency room physician and 
it’s a crapshoot.… Most of these guys – don’t 
know enough about HIV PEP to order it. It is 
kind of scary! You’re the emergency doctor. 
You should know. (FG 2 R 1, program 
coordinator [SANE]) 
I think a lot of physicians are just so set in 
their ways and so interested in not being 
proven wrong about something. … Or not 
willing to take the chance that maybe they’re 
wrong. Because I know the one that we’ve had 
problems with, she keeps quoting statistics that 
she’s pulled off the internet. … But when we 
try to counteract it, she says well, hers are 
right and ours are wrong. Well, at two o’clock 
in the morning, it’s a little difficult to deal with 
that. (FG 2 R 2, nurse; also Surv R 53) 
One of the issues we’ve struggled with is 
certain doctors where you know they say, ‘Oh, 
it’s a partner assault, well, there’s no risk 
there. She’s been consenting to have sex with 
him for a long period of time.’ (FG 3 R 2, 
program coordinator [SANE]) 
  An emergency room physician himself added that a too 
limited “knowledge of drugs and toxicities” would be a 
barrier to a sustainable HIV PEP program (Surv R 103). His 
colleague, also an emergency room physician, was 
additionally concerned that, “there is universal shortage of 
all health care providers; this is another ‘job’ to be done. The 
number of jobs, complexity, is rising and the number who 
can do this is falling” (Surv R 114). 
Commitment 
Lack of Institutional Support 
  Some health care provider respondents identified a lack 
of institutional support as a barrier to an ongoing HIV PEP 
Program. According to a program medical director, his 
“hospital would not cover 1/12 of the cost of medications” 
(Surv R 22). A program coordinator (SANE) emphatically 
stated that she had also experienced administrative resistance 
to the program, “from the hospital, big time” (FG 2 R1). She 
elaborated: 
If the hospital wasn’t being reimbursed, I don’t 
think they’d do it any more. … Because that’s 
all we ever hear… They have told us, once this 
study is over, then we won’t be offering this. 
(FG 2 R1) 
  She also noted that specific hospital staff “were totally 
against it” (FG 2 R1): 
Our pharmacy makes, I can’t remember, I 
mean, the way we pay for the medication is 
just absolutely ridiculous …. It was the Chief, 
the Head Pharmacist … who disagreed with 
the protocol; who thinks the medications are 
unsafe. It’s just unbelievable! (FG 2 R1) 
  Another program coordinator (SANE) mentioned that she 
too “had a wee bit of hassle with the pharmacist at her 
hospital” (FG 4 R4): 
She feels that it’s additional work for her to 
get the medications and she’s not getting 
financial compensation or whatnot for doing it. 
She thinks that it’s a bit of a hardship and I’ve 
had to go to pharmacy myself every time to 
get the follow-up drugs. They’ve never been 
brought up to the Emergency Department 
where we supply it. (FG 4 R4) 
Physician Resistance to Offering HIV PEP 
  Many health care provider respondents also stated that 
they “had a lot of problems with … physicians” refusing to 
support the HIV PEP Program (FG 2 R1, program 
coordinator [SANE]; also Surv Rs 48, 72). Comments 
focussed on “on-going issues with some … emergency room 
doctors” (Surv R 53, SANE) “just absolutely refusing to 
order” the medications (FG 2 R1, program coordinator 
[SANE]; also FG 2 R 2, FG 3 R 2; Surv Rs 42, 67, 75, 105): 
Emergency room physicians who work with us 
feel the risk of therapy outweighs HIV 
seroconversion risk. They have frequently 
refused to order HIV PEP. (Surv R 44, SANE) 
The majority … of our ER doctors … is great 
and accepts our recommendation. However, 
we have a couple who really give us a hard 
time. This certainly increases the stress level 
of our team. (Surv R 53, SANE) 
It happens with our doctors all the time. … 
The nurses who are on call will call me at 
home, and ask questions and I mean, it’s 
usually … go ask the physician, but they’re 
not going to order it anyway. And most of the 
time they don’t. It surprises me when the ER 
doctors do order it. … They have absolutely 
no interest whatsoever. (FG 2 R 1, program 
coordinator [SANE]) 
  This latter program coordinator continued: 
The only thing I don’t feel good about in 
offering to everyone is … talking to these 
women, would you be interested in this 
medication? It’s very, very difficult when … 
they answer “yes, I’d be interested”. So you 
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physician who refuses to order the medication. 
(FG 2, R 1, program coordinator [SANE]) 
  One SANE colleague noted a particularly upsetting 
incident with a physician at her centre: 
We had one instance with one doctor – it 
wasn’t the same one as usually gives us a hard 
time – she actually went in and told the patient 
that if it was her daughter she wouldn’t 
recommend the medications because of the 
side effects. Anyway, we had quite a little to-
do about that. (FG 2 R2) 
Accommodation 
Lack of Flexibility in Addressing Specific Client and 
Community Needs 
  An important barrier to program sustainability was 
identified by several respondents as a lack of flexibility in 
the way in which the HIV PEP care itself was delivered. A 
program coordinator (SANE) whose centre serves a rural 
population was resolute, “it has to be something that 
becomes a flexible type of protocol or situation” (FG 4 R 2; 
also, FG 1 R 2, FG 4 R 1; Surv R 83). 
 Her  colleague  concurred: 
Because something may happen or clients may 
be a no show and because of transportation 
reasons or whatever, in a rural area, they may 
not be able to get in for follow-up. (FG 4 R4, 
program coordinator [SANE]) 
 This  issue  was  identified  as  especially  relevant  to  centres 
serving “remote Aboriginal communities” (FG 3 R 3, 
program coordinator [SANE]): 
I think that we can keep the program going but 
I think that it needs a few modifications … to 
make it sustainable. Because our clients are 
from the north, I think we have to involve the 
nursing stations more and I think we’re going 
to have to look at not as much follow-up 
unfortunately and giving more medications out 
at each interview. (FG 3 R 3, program 
coordinator [SANE]) 
Some of the other barriers that we have locally 
are in dealing with First Nations persons being 
able to get in because some of the women are 
two and three hours away. And getting back 
and forth with the follow-up, that’s something 
we’ve got to look at to come up with some 
better creative ways about dealing with it. (FG 
4 R 2, program coordinator [SANE]) 
  This latter health care provider mentioned attempts to 
connect with nurses on the reserve to support the 
implementation of the HIV PEP Program, but continued that 
they “were in a constant state of flux” and, therefore, “were 
very reluctant” to get involved. She emphasized that this 
would be an ongoing issue for offering HIV PEP 
medications and preventing unnecessary “drop offs” from 
the program (FG 4 R 2, program coordinator [SANE]). 
 
Inaccessibility and Lack of Clarity of Tools 
  Certain study tools were also cited as problematic in 
sustaining the HIV PEP Program in an ongoing manner 
(Surv R 81). One issue raised by several health care 
providers was what they believed to be the inappropriate 
literacy level required to read client handouts: 
I think that with working with different 
populations as well, not everyone is literate 
and not everyone can read English. … So 
maybe making the material a little more user 
friendly so if they decide to go on the HIV 
PEP … they have something … with pictures 
or other things as opposed to the written 
booklet; it’s a bit heavy. (FG 4 R 3, SANE; 
also FG 4 R 4) 
  A SANE colleague agreed, “I would like to see more 
‘readable’ information – the average person reads at about a 
grade 6 level” (Surv R 37). A “need for more culturally 
sensitive food choice selections in the client information 
booklet” was also mentioned as important by another SANE 
who “had several Spanish only speaking clients on PEP” 
(Surv R 3). 
  There were also some concerns with the nursing tools. 
One nurse noted in referring to the documentation form for 
initial visits, “that white sheet is confusing. … The one you 
tick off everything. … I mean it just doesn’t flow easily for 
me. It’s really hard to concentrate at two o’clock in the 
morning” (FG 1 R 7). A program coordinator (SANE) stated, 
“I am hoping that … separate documentation tools for HIV 
will be incorporated into our standard documentation 
tools…that sort of thing will help the staff considerably” (FG 
3 R 2; also Surv R 37). Her colleague added, “If there is a 
reduction in paperwork. I think they’re going to be excited to 
continue offering the medications to clients” (FG 3 R1, 
program coordinator [SANE]). 
DISCUSSION 
  Although the experienced health care providers surveyed 
and interviewed for this study for the most part believed that 
a program of universal offering of HIV PEP could be 
implemented, a substantial proportion identified important 
barriers to sustainability. Survey and focus group 
respondents felt that a lack of resources, expertise, 
commitment, and accommodation presented major obstacles 
to an ongoing and viable program of care. Among the 
particular challenges noted, a lack of funds to pay for HIV 
PEP medications and to hire new staff as well as to 
compensate appropriately those already employed, were seen 
as major impediments—perhaps not surprising given the 
economic climate at the time—as captured by one program 
coordinator (SANE), interviewed in one of the four focus 
groups: 
We’re in the midst of our balanced budget 
fiasco with cuts being announced in our 
regional health centre so at this point in time 
everything is in flux and everyone is trying to 
save their jobs and save money. … In addition 
to just what’s happening in the hospital – our 
program, where we are, at women’s health 
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support staff wise and having a nurse 
practitioner, is going to change dramatically. 
  Other studies evaluating the use of PEP post sexual 
assault in countries with low prevalence rates of HIV have 
also noted that the cost of antiretroviral medications is “one 
of the greatest hurdles in implementing this type of protocol” 
(18: p.5, see also 41). One physician in our study projected 
that if the number of sexual assault survivors seeking HIV 
PEP increased over time, a lack of monies would lead to 
difficult decisions around “who really warrants” the 
expensive medications—an issue already the subject of 
wide-spread debate. Although the universal use of HIV PEP 
where the source is presumed unlikely to be HIV infected 
may not be cost-effective [11, 65-67], it is challenging to 
accurately identify those at high risk of HIV, thus making 
HIV PEP programs that target high risk victims only very 
difficult to implement. 
  Many of the other problems identified as barriers to 
sustaining an HIV PEP Program also have financial 
implications. The data indicated that if an HIV PEP Program 
offering universal care was to be implemented further 
external funding would be necessary, not just to 
accommodate the costs of the drugs and staff, but to hire 
outside supports such as HIV experts, who could consult on 
complex cases and ensure that the program client handouts 
and the protocol itself reflected the most current information 
available about HIV in the sexual assault context. These 
issues were of particular concern to staff at centres in smaller 
cities and towns in the north, where they stated there was a 
“need to ensure that all clients no matter where they live or 
seek treatment have the same resources” (Surv R 126). In 
these areas, health care providers also argued adamantly that 
any viable HIV PEP program of care would have to better 
accommodate unique community needs. This was stated to 
be of particular relevance to those serving the following: 1) 
multicultural clients for whom handouts would be needed in 
different languages, as well as redeveloped at lower literacy 
levels in English; and 2) Aboriginal persons, for whom 
follow-up was often difficult, due to travelling two or three 
hours to be seen. In the latter instance, this would seem 
crucial given that Aboriginal survivors may come from 
communities disproportionately affected by sexually 
transmitted infections and with limited access to health care 
services [68, 69]. Moreover, there is research that supports 
the “feasibility and practicality” of dispensing the full PEP 
regimen on the initial visit for those unable to return easily 
due to logistical reasons [70]. 
  Another important barrier to sustaining an HIV PEP 
Program was identified as a lack of support from hospitals 
and certain groups of health care professionals working 
within them. Although some nurse respondents had 
experienced difficulties with some pharmacists who felt that 
they were not being adequately compensated for their time, 
most resistance was stated to have come from physicians 
who did not want to prescribe the PEP. Emergency room 
physicians sometimes disagreed with the program protocol 
believing that the side-effects outweighed the benefits of 
offering the medications universally and in cases of intimate 
partner sexual assault. This fact was attributed by nurses to a 
deficit in physician expertise and experience with use of HIV 
drugs in the sexual assault context. An emergency room 
physician himself agreed that an inadequate knowledge 
about HIV medications and their possible side-effects would 
be a road block to province-wide implementation of an HIV 
PEP program. To be sure, physicians need to be familiar 
with various related HIV medications. However, at the same 
time, it must also be acknowledged that other health care 
providers have queried the value of a universal approach to 
offering HIV PEP to sexual assault survivors and in 
circumstances specifically in which there is ongoing 
exposure from an intimate assailant [11, 41, 50]. With regard 
to the latter, we agree with the World Health Organization 
that in these situations there must be a simultaneous focus on 
risk reduction and prevention [24]. 
  This study had several limitations that warrant 
discussion. In regard to the survey, the low response rate – a 
characteristic of questionnaires generally of different types 
of health care provider groups [e.g., 71, 72-74] – may have 
resulted in self-selection bias. Administrators, nurses, 
physicians, social workers, and pharmacists who were most 
supportive of the HIV PEP Program may have been 
overrepresented in the sample, which may have 
compromised our ability to capture and later address the full 
range of barriers to the sustainability of such a program of 
care. A similar self-selection bias may have affected the 
results of the focus groups, where our findings also may not 
have fully reflected the opinions and experiences of all 
health care providers involved in offering the HIV PEP 
Program. However, despite these limitations, our study 
provides an opportunity for other jurisdictions to learn from 
the challenges that may arise in implementing and sustaining 
an HIV PEP program for survivors of sexual assault. It also 
allowed us to take steps systematically to address identified 
barriers to ensure that the offering of HIV PEP care could be 
successfully incorporated into standards of sexual assault 
care for Ontario. 
Responding to Barriers to HIV PEP Program 
Implementation 
  In February 2006, to address the most commonly noted 
barrier to an ongoing HIV PEP Program – the cost of 
medications – we approached the Ontario government for 
funding. Based on the recommendations arising from the 
HIV PEP Study data, the Ministry of Health and Long-term 
Care agreed to pay for a program of universally offering HIV 
PEP medications at all 34 provincial SA/DVTCs. 
Subsequently, we undertook a Knowledge-to-Action (KTA) 
Project [75] for the purpose of identifying strategies that 
might address the remaining threats to the viability of a long 
term program of HIV care. At the Network of SA/DVTC’s 
Annual Meeting in May 2006, and subsequently in several 
focus groups, health care providers were interviewed to aid 
in this process. 
 Almost all health care provider identified 
challenges/barriers to successful implementation of the HIV 
PEP Program were mapped to two tangible methods to 
address them: 1) adaptation and dissemination of, and 
training using revised, HIV PEP Study tools; and 2) 
establishment of an ongoing HIV PEP Expert Group. A KTA 
Project Advisory Committee comprised of HIV experts, 
SA/DVTC decision-makers and front-line staff, and 
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revising and rolling out revised materials, and later formed 
the basis of the Expert Group. 
Revision of the HIV PEP Study Tools 
  Subsequent to the Network’s Annual Meeting, a working 
group composed of select KTA Project Advisory Committee 
members was formed to assist with the actual adaptation of 
the tools and external consultations were held as needed with 
regard, in particular, to the client handout design and 
language simplification. Materials revised included: 1) 
Medical guidelines; 2) Initial visit flow sheet; 3) Follow-up 
flow sheet; 4) Client information handouts: a) HIV risk 
assessment pamphlet and b) HIV PEP information booklet; 
5) Client scenarios for health care providers; 6) Fact sheets 
for physicians; 7) Fact sheets for pharmacists; 8) Fact sheets 
for other health care providers; 9) Fact sheets for clients; and 
10) Orientation to HIV PEP Program power point 
presentation. These new materials were designed to provide 
updated, streamlined evidence-based guidelines and user-
friendly information at appropriate literacy levels to support 
all health care providers involved in offering, and diverse 
clients in accepting, the HIV medications. Given problems 
that arose during the HIV PEP Study with some health care 
provider resistance to the protocol, their purpose was also to 
aid in enhancing interprofessional collaboration based on 
clarity of roles and responsibilities and improved 
communication within teams and between SA/DVTCs and 
other departments such as emergency medicine and 
pharmacy. Because a lack of flexibility in the delivery of the 
HIV PEP Program was also seen as a barrier to 
implementation, the revised tools were designed more 
generically – so that as a whole, they could function as a 
framework from which some processes could be tailored 
locally to address the specific needs of communities while 
maintaining a core protocol that would ensure quality of 
service delivery. The revised documents, which were 
reviewed by the entire Advisory Committee for clarity, 
conciseness, comprehensiveness, and utility of information 
and piloted at several SA/DVTCs, were favourably received. 
A website to house the final tools was created to ensure ease 
of access for health care providers and clients (available 
from www.sadvtreatmentcentres.net/HIVPEP). 
Rollout of the Revised HIV PEP Study Tools 
  Beginning January 2007, orientation and training 
sessions, based on the revised tools, were developed, piloted 
at several SA/DVTCs, and delivered to health care providers 
and hospital policy makers across six regions of Ontario 
using a “train-the-trainer” model (SM). Following these 
sessions, nine interactive web-based modules were 
developed as a permanent reference guide (Background on 
HIV and HIV in Ontario, HIV PEP Study findings, The 
current HIV PEP Program, HIV PEP drug information, 
Initial visit and HIV risk assessment, Pre- and post-HIV test 
counselling, When to consult an HIV specialist, Follow-up 
visit and counselling, and HIV PEP side effects and 
management), which also contained the contact information 
of available local HIV experts for consultation. This online 
educational program, which addressed the issue of a lack of 
sufficient training and expertise among clinicians, also 
reduced the costs of in-person training, important given high 
staff turnover at SA/DVTCs [62]. Qualitative feedback in the 
form of pre- and post-evaluation surveys indicated that the 
final online modules were successful in their deliverables 
and provided a comprehensive and sufficient core training 
program and a user-friendly interface on which to efficiently 
learn HIV PEP treatment and counselling protocols 
(available from www.sadvtreatmentcentres.net). The 
Network website, with these assessment and 
diagnostic/treatment tools, has become an important source 
for health care providers for continuous learning, ongoing 
skill upgrades, and HIV PEP awareness and competence, as 
well as for current information for community partner 
organizations, survivors of sexual violence, and the public. 
Establishment of a Permanent HIV PEP Expert Group 
  In January 2008, a permanent HIV PEP Expert Group 
was formed and continues to include three infectious disease 
specialists from across Ontario, one pharmacist with HIV 
expertise, one SA/DVTC program coordinator (SANE), one 
SA/DVTC follow-up nurse (SANE), and the provincial 
coordinator (SANE) of the Ontario Network of SA/DVTCs. 
The mandate of this Expert Group is to review the current 
HIV PEP drug regimen and the medical protocols and 
pamphlets used and to address other relevant medical issues 
on an annual basis. New data that are identified that could 
shape the ways in which the HIV PEP Program of care is 
offered are discussed and recommendations for changes 
made to the Network of SA/DVTCs. Establishment of this 
group has addressed concerns raised by health care provider 
respondents for the need for external experts for support to 
ensure the long-term sustainability and coordination of the 
HIV PEP Program as part of the standard of care for 
survivors of sexual assault in Ontario. 
CONCLUSION 
  This study revealed that multiple barriers can converge to 
prevent the implementation and sustainability of an HIV PEP 
Program of care to sexual assault survivors, including 
inadequate resources, expertise, commitment, and 
accommodation to unique community needs. However, 
identifying these challenges has led to efforts to address 
them: the creation of easy access web-based tools, the ability 
to self-assess knowledge and skills, and the access to local 
and centralized HIV experts. These measures have provided 
SA/DVTC staff with the capacity to effectively respond to 
the particular challenges that may arise in the future in their 
facilities as well as to the needs of individual survivors who 
may require HIV PEP and/or treatment. This has been 
particularly important for staff who have limited or 
infrequent experience in addressing HIV prophylactic care 
post sexual assault. Although addressing the need for more 
staff to better offer HIV PEP care specifically, and sexual 
assault care more generally, remains an ongoing issue for the 
Network, since the original HIV PEP Study, the universal 
offering of antiretroviral medications has become a standard 
of care at all 35 SA/DVTCs in Ontario and uptake and 
completion rates have increased by 8% (2003-2005: 32% v. 
2008-2010: 40%). Based on this success, we continue to 
build the capacity of the Network to respond in an evidence-
based manner to issues arising in providing sexual assault 
care by further enhancing research/clinical [e.g., 76, 77, 78] 
and hospital/stakeholder relationships (e.g., collaborations 110    The Open AIDS Journal, 2011, Volume 5  Du Mont et al. 
with Ontario Women’s Directorate and ECHO, an Agency of 
the Ontario Ministry of Health and Long-Term Care). 
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